‘Pfizer Inc. said 2006 net income will rise 40 percent as the world’s largest drugmaker enters the second year of a $4 billion cost-cutting plan.
Earnings this year will rise to $11.4 billion to $11.7 billion, or $1.52 to $1.56 a share, from $8.09 billion, or $1.09, in 2005, Pfizer said today in a statement as executives met with analysts at a meeting in New York. Profit excluding depreciation and expenses related to cost cutting will be about $2 a share, compared with this year’s $2.02.’
Read more at Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax